Franziska Eberhardt
Overview
Explore the profile of Franziska Eberhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang G, Neuber B, Huckelhoven-Krauss A, Hopken U, Ding Y, Sedloev D, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338672
The search for target antigens for CAR-T cell therapy against multiple myeloma defined the B-cell maturation antigen (BCMA) as an interesting candidate. Several studies with BCMA-directed CAR-T cell therapy showed...
2.
Eberhardt F, Huckelhoven-Krauss A, Kunz A, Jiang G, Sauer T, Reichman A, et al.
Int J Mol Med
. 2023 Jun;
52(1).
PMID: 37264971
Fetal bovine serum (FBS) or human serum is widely used in the production of chimeric antigen receptor (CAR) T‑cells. In order to overcome a lot‑to‑lot inconsistency, the use of chemically...
3.
Reichman A, Kunz A, Joedicke J, Hopken U, Keib A, Neuber B, et al.
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35055086
Chimeric-antigen-receptor (CAR)-T-cell therapy is already widely used to treat patients who are relapsed or refractory to chemotherapy, antibodies, or stem-cell transplantation. Multiple myeloma still constitutes an incurable disease. CAR-T-cell therapy...